期刊文献+

MACC1和C-met蛋白在食管癌中的表达及意义 被引量:6

Expression and prognostic significance of MACC- 1 and C- met in esophageal cancer
在线阅读 下载PDF
导出
摘要 目的:观察结肠癌转移相关基因(MACC1)和肝细胞生长因子受体(C-met)蛋白在食管癌中的表达及意义。方法:采用免疫组织化学En Vinsion法检测88例食管癌组织中MACC1和C-met蛋白的表达情况,分析两者与食管癌病理分级、临床分期的关系及两者在食管癌组织中表达的相关性。结果:MACC1和Cmet在食管癌组织中的阳性率分别为88.64%和75.00%。在食管癌中MACC1和C-met蛋白高表达与临床分级、分期显著相关(P<0.001)。进一步分析显示食管癌组织中MACC1和C-met蛋白表达具有相关性。结论:食管癌组织中MACC1、C-met及其蛋白表达水平增高,C-met通路的激活和MACC1过表达可能与食管癌的发生、发展有关,MACC1和C-met具有作为食管癌分子标志物的潜在价值。 Objective:To investigate the exPressions and Prognostic significance of metastasis-associated in colon cancer 1(MACC1)and hePatocyte growth factor recePtor(C-met)in esoPhageal cancer. Methods:The exPression of MACC1 and C -met in 88 cases of Primary esoPhageal cancer were detected by immunohistochemical staining method. Results:The exPressions of MACC1 and C-met were significantly higher in esoPhageal cancer. The high ex-Pressions of MACC 1 and C -met were significantly related to differential Pathological stage and TNM stage( P〈0. 001),but not with gender,age. A Positive correlation was found between the high exPressions of MACC1 and C-met. Conclusion:The high exPressions of MACC1 and C-met may Play an imPortant role in the develoPment,Pro-gression and metastasis of esoPhageal cancer. The combined detection of MACC1 and C-met can be used to deter-mine the biological behavior and Prognosis of esoPhageal cancer.
出处 《现代肿瘤医学》 CAS 2015年第13期1843-1846,共4页 Journal of Modern Oncology
关键词 食管癌 MACC1 C-MET esoPhageal cancer MACC1 C-met
  • 相关文献

参考文献10

  • 1Hao Jie, Shao Kang. The epidemiology status and the treatment of e-sophageal cancer in China [ J ]. J Cancer in China,2011,21 (7):501 -504.
  • 2Shimadah,Shiratori T,0kazumi S,et al. Have surgical outcomes ofpathologic T4 esophageal squamous cell carcinoma really improved.Analysis of 268 cases during 45 years of experience[ J]. J Am CollSurg,2008,206( 1):48 -56.
  • 3Stein U, Walther W, Arh F, et al. MACC1 , a newly identified keyregulator of HGF - MET signaling t predicts colon cancer metastasis[J].Nat Med,2009,15(l) :59 -60.
  • 4Shirahata A,Fan W,Sakuraba K,et al. MACC1 as a marker for vas-cular invasive epatocellular carcinoma [ J ] . Anticancer Res, 2011 ,31(3) :777 -780.
  • 5Shirahata A,Sakata M,Kitamura Y,et al. MACC1 as a marker forperitonealdisseminated gastric carcinoma [ J ]. Anticancer Res,2010,30(9):3441 -3444.
  • 6Qiu J, Huang P, Liu Q,et al. Identification of MACC1 as a novelprognostic marker in hepatocellular carcinoma[ J ]. J Transl Med,2011,9:166.
  • 7Eder JP, Vande Woude GF,Boemer SA,et al. Novel therapeutic in-hibitors of the c - met signaling pathway in cancer[ J]. Clin CancerRes,2009,15(7) :2207 -2214.
  • 8Graveel CR,DeGroot JD,Su Y ,et al. Met induces diverse mammarycarcinomas in mice and is associated with human basal breast canc-er[J].Proc Natl Acad Sci USA,2009,106(31) : 12909 - 12914.
  • 9Hu Wen Sheng, Fu Xi. Expression and prognostic significance ofMACC1 and C - met in non - small cell lung cancer [ J ]. J LungCancer in China,2012,15(7) :399 -403.
  • 10Zhang R,Shi H,Chen Z ,.et al. Effects of metastasis - associated incolon cancer inhibition by small hairpin RNA on ovarian carcino-ma OVCAR -3 cells[ J]. J Exp Clin Cancer Res,2011,30:83.

同被引文献44

  • 1杨玲,李连弟,陈育德,D.M.Parkin.中国2000年及2005年恶性肿瘤发病死亡的估计与预测[J].中国卫生统计,2005,22(4):218-221. 被引量:336
  • 2Osterhues A, Ali NS, Michels KB. The role of folic acid fortificationin neural tube defects:a review[J]. Crit Rev Food Sci Nutr, 2013,53(11) :1180 -1190.
  • 3Walters CL, Arend RC, Armstrong DK, et al. Folate and fo- late receptor alpha antagonists mechanism of action in ovarian eaneer[J].Gynecol Oncol,2013,131(2) :493-498.
  • 4Ozawa Y,Nakamura Y,Fujishima F,et al. c-Met in esophageal squamous cell carcinoma:an independent prognostic factor and potential therapeutic target [J]. BMC Cancer, 2015,15:451.
  • 5Gual P,Giordano S,Anguissola S,et al. Differential re- quirement of the last C-terminal tail of Met receptor for cell transformation and invasiveness [J]. Oncogene, 2001,20(39) : 5493-5502.
  • 6Cui JJ. Targeting receptor tyrosine kinase MET in cancer: small molecule inhihitors and clinical progress [J].J Med Chem, 2014,57(11) :4427-4453.
  • 7Amemiya H, Menolascino F,Pena A. Role of the expres- sion of c-Met receptor in the progression of gastric cancer [J].Invest Clin, 2010,51(3) : 369-380.
  • 8Tuynman JB,Lagarde SM,ten Kate FJW,et al. Met ex- pression is an independent prognostic risk factor in pa- tients with oesophageal adenocarcinoma [J]. Br J Cancer, 2008,98(6) : 1102-1108.
  • 9Scarpion S, Durantu E,Stoppacciaro A,et al.COX-2 is in- duced by HGF stimulation in MET-positive thyroid papil- lary carcinoma cells and is involved in tumor invasiveness [J].Pathol, 2009,218(4) : 487-494.
  • 10Goyal L,Muzumdar MD,Zhu AX. Targeting the HGF/c- Met pathway in hepatocellular carcinoma [J]. Clin Cancer Res,2013,19(9):2310-2318.

引证文献6

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部